On air · 1 of 3 networks
bioLytical
- biolytical.com
- Healthcare & Life Sciences
- CA
- 101 employees
bioLytical’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 132. Watch bioLytical with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 87 | Checked 30 Oct 2026 | See all 132 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 18 Oct 2026 | Collect them with the API → |
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 11 Oct 2026 | Collect them with the API → |
bioLytical has 87 live LinkedIn ads. Its Facebook page had no active ads on 18 Oct 2026, and we recorded no Google ads on 11 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 30 Sept 2026
bioLytical Laboratories, the creator of the INSTI® rapid test platform, is expanding its distribution network in Italy, Spain, and Bulgaria. We are looking for established medical device distributors ready to bring a game changing diagnostic technology to their market. Why INSTI®? INSTI® delivers results in as little as 60 seconds, making it the world's fastest rapid test platform overall. No other rapid test on the market matches this speed, giving your customers a true competitive edge in point of care and self testing settings. Our Portfolio: INSTI® HIV Self Test INSTI® HIV-1/HIV-2 Antibody Test INSTI® Multiplex HIV-1/HIV-2/Syphilis Antibody Test INSTI® Hepatitis C Antibody Test What Makes INSTI® a Strong Opportunity for Distributors: Unmatched speed: results in 60 seconds, faster than any competing rapid test High accuracy: clinically validated sensitivity and specificity Proven global brand: trusted by health ministries, NGOs, and healthcare providers worldwide Broad portfolio: one partner, multiple test lines across HIV, syphilis, and hepatitis C Distributor support: training, marketing materials, and regulatory guidance provided Growing market demand: rising need for decentralized, self administered, and point of care testing Who We're Looking For: Medical device distribution companies in Italy, Spain, or Bulgaria with: 🔵 Established relationships with pharmacies, clinics, hospitals, or public health bodies 🔵 Regulatory and logistics capability to bring IVD products to market 🔵 A commitment to expanding access to fast, reliable diagnostic testing
- LINKEDIN · IMAGESince 30 Sept 2026
bioLytical Laboratories, the creator of the INSTI® rapid test platform, is looking for established medical device distributors in Belgium to partner with us on the INSTI® HIV Self Test. ⚡ Results in as little as 60 seconds, faster than any other HIV self test on the market ✅ Clinically validated sensitivity and specificity 🏠 Simple, private testing people can do at home 🌍 Trusted by health ministries, NGOs, and healthcare providers worldwide As demand grows for convenient, self administered testing, INSTI® gives your customers a fast, reliable option and gives your business a true competitive edge. Who we're looking for: Medical device distributors in Belgium with established relationships with pharmacies, clinics, hospitals, or public health bodies, plus the regulatory and logistics capability to bring IVD products to market. What you'll get: Training, marketing materials, and regulatory guidance to help you launch and grow. 👉 Apply now to become an official INSTI® distributor in Belgium.
- LINKEDIN · IMAGESince 1 Sept 2026
bioLytical Laboratories, the creator of the INSTI® rapid test platform, is expanding its distribution network in Italy. We are looking for established medical device distributors ready to bring a game changing diagnostic technology to their market. Why INSTI®? INSTI® delivers results in as little as 60 seconds, making it the world's fastest rapid test platform overall. No other rapid test on the market matches this speed, giving your customers a true competitive edge in point of care and self testing settings. Our Portfolio: INSTI® HIV Self Test INSTI® HIV-1/HIV-2 Antibody Test INSTI® Multiplex HIV-1/HIV-2/Syphilis Antibody Test INSTI® Hepatitis C Antibody Test What Makes INSTI® a Strong Opportunity for Distributors: Unmatched speed: results in 60 seconds, faster than any competing rapid test High accuracy: clinically validated sensitivity and specificity Proven global brand: trusted by health ministries, NGOs, and healthcare providers worldwide Broad portfolio: one partner, multiple test lines across HIV, syphilis, and hepatitis C Distributor support: training, marketing materials, and regulatory guidance provided Growing market demand: rising need for decentralized, self administered, and point of care testing across Europe Who We're Looking For: Medical device distribution companies in Italy with: 🔵 Established relationships with pharmacies, clinics, hospitals, or public health bodies 🔵 Regulatory and logistics capability to bring IVD products to market 🔵 A commitment to expanding access to fast, reliable diagnostic testing Apply now to become an official INSTI® distributor in your country.
- LINKEDIN · IMAGESince 1 Sept 2026
bioLytical Laboratories, the creator of the INSTI® rapid test platform, is expanding its distribution network in Croatia, Bulgaria, Romania, and Austria. We are looking for established medical device distributors ready to bring a game changing diagnostic technology to their market. Why INSTI®? INSTI® delivers results in as little as 60 seconds, making it the world's fastest rapid test platform overall. No other rapid test on the market matches this speed, giving your customers a true competitive edge in point of care and self testing settings. Our Portfolio: INSTI® HIV Self Test INSTI® HIV-1/HIV-2 Antibody Test INSTI® Multiplex HIV-1/HIV-2/Syphilis Antibody Test INSTI® Hepatitis C Antibody Test [iStatis tests coming to your market soon] What Makes INSTI® a Strong Opportunity for Distributors: Unmatched speed: results in 60 seconds, faster than any competing rapid test High accuracy: clinically validated sensitivity and specificity Proven global brand: trusted by health ministries, NGOs, and healthcare providers worldwide Broad portfolio: one partner, multiple test lines across HIV, syphilis, and hepatitis C Distributor support: training, marketing materials, and regulatory guidance provided Growing market demand: rising need for decentralized, self administered, and point of care testing across Europe Who We're Looking For: Medical device distribution companies in Croatia, Bulgaria, Romania, or Austria with: 🔵 Established relationships with pharmacies, clinics, hospitals, or public health bodies 🔵 Regulatory and logistics capability to bring IVD products to market 🔵 A commitment to expanding access to fast, reliable diagnostic testing Apply now to become an official INSTI® distributor in your country. Note: Our iStatis tests are coming soon to your market. Join us now to be among the first to offer them.
- LINKEDIN · IMAGESince 1 Sept 2026
bioLytical Laboratories, the creator of the INSTI® rapid test platform, is expanding its distribution network in Croatia, Bulgaria, Romania, and Austria. We are looking for established medical device distributors ready to bring a game changing diagnostic technology to their market. Why INSTI®? INSTI® delivers results in as little as 60 seconds, making it the world's fastest rapid test platform overall. No other rapid test on the market matches this speed, giving your customers a true competitive edge in point of care and self testing settings. Our Portfolio: INSTI® HIV Self Test INSTI® HIV-1/HIV-2 Antibody Test INSTI® Multiplex HIV-1/HIV-2/Syphilis Antibody Test INSTI® Hepatitis C Antibody Test What Makes INSTI® a Strong Opportunity for Distributors: Unmatched speed: results in 60 seconds, faster than any competing rapid test High accuracy: clinically validated sensitivity and specificity Proven global brand: trusted by health ministries, NGOs, and healthcare providers worldwide Broad portfolio: one partner, multiple test lines across HIV, syphilis, and hepatitis C Distributor support: training, marketing materials, and regulatory guidance provided Growing market demand: rising need for decentralized, self administered, and point of care testing across Europe Who We're Looking For: Medical device distribution companies in Croatia, Bulgaria, Romania, or Austria with: 🔵 Established relationships with pharmacies, clinics, hospitals, or public health bodies 🔵 Regulatory and logistics capability to bring IVD products to market 🔵 A commitment to expanding access to fast, reliable diagnostic testing Apply now to become an official INSTI® distributor in your country.
- LINKEDIN · IMAGESince 22 Jul 2026
Here’s the reality: healthcare providers around the world are still waiting too long for rapid test results. Meanwhile, INSTI is delivering answers in just 60 seconds across 59 countries. We’ve spent years perfecting flow-through technology designed to reduce waiting times. More than 15 million INSTI tests have been performed, supported by accuracy rates of up to 99.8%. We’ve also built a comprehensive rapid testing portfolio spanning HIV, HCV, and multiplex testing. Now, we’re looking for distribution partners who share our vision: healthcare providers and patients everywhere deserve faster, simpler, and more accurate testing. What You’ll Distribute: INSTI HIV-1/HIV-2 Antibody Test – The professional standard INSTI HCV Antibody Test – Expanding access to comprehensive diagnostics INSTI Multiplex Syphilis/HIV-1/HIV-2 Test – Multiple infections, one minute What You’ll Get: ✓ Innovative products that stand out in the market ✓ Global credibility that opens doors ✓ Marketing support, training, and regulatory guidance ✓ Competitive margins on proven technology ✓ A brand trusted by healthcare providers in 59+ countries If you’re a medical device distributor ready to help transform rapid diagnostics in your market, we should talk.
6 of 132 adsSign up to see every bioLytical ad, filter by format and date, and get alerts on new ones.
See all 132 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.